Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments.
Zugbi S, Aschero R, Ganiewich D, Cancela MB, Winter U, Ottaviani D, Sampor C, Dinardi M, Torbidoni AV, Mena M, Balaguer-Lluna L, Lamas G, Sgroi M, Lagomarsino E, Lubieniecki F, Fandiño A, Radvanyi F, Abramson DH, Podhajcer O, Llera AS, Cafferata EG, Chantada G, Carcaboso AM, Schaiquevich P.
Zugbi S, et al. Among authors: lagomarsino e.
Invest Ophthalmol Vis Sci. 2023 Dec 1;64(15):27. doi: 10.1167/iovs.64.15.27.
Invest Ophthalmol Vis Sci. 2023.
PMID: 38117242
Free PMC article.